Express Scripts Holding Market Cap 2006-2018 | ESRX

Historical market capitalization for Express Scripts Holding (ESRX) over the last 10 years. The current market cap for Express Scripts Holding (ESRX) as of March 31, 2018 is $45.46B.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.401B 24.84
PRA Health Sciences (PRAH) United States $6.377B 30.53
Charles River Laboratories (CRL) United States $5.637B 21.91
INC Research Holdings (SYNH) United States $5.036B 22.17
Premier (PINC) United States $4.978B 20.13
HealthEquity (HQY) United States $4.975B 105.50
Teladoc (TDOC) United States $4.180B 0.00
NovoCure (NVCR) Jersey $3.224B 0.00
AMN Healthcare Services Inc (AMN) United States $2.859B 21.81
Intrexon (XON) United States $1.883B 0.00
BioTelemetry (BEAT) United States $1.613B 44.73
Medpace Holdings (MEDP) United States $1.584B 25.19
IKang Healthcare (KANG) China $1.418B 78.54
Healthways (TVTY) United States $1.412B 20.00
Natera (NTRA) United States $1.241B 0.00
China Cord Blood (CO) China $0.958B 25.61
Apollo Medical Holdings (AMEH) United States $0.801B 0.00
Surgery Partners (SGRY) United States $0.743B 0.00
Civitas Solutions (CIVI) United States $0.590B 15.05
CareDx (CDNA) United States $0.431B 0.00
OncoCyte (OCX) United States $0.114B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.016B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00